• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙胺丁醇和异烟肼协同作用对抗 的分子机制。

Molecular mechanism of the synergistic activity of ethambutol and isoniazid against .

机构信息

From the National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.

From the National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, China

出版信息

J Biol Chem. 2018 Oct 26;293(43):16741-16750. doi: 10.1074/jbc.RA118.002693. Epub 2018 Sep 5.

DOI:10.1074/jbc.RA118.002693
PMID:30185616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6204910/
Abstract

Isoniazid (INH) and ethambutol (EMB) are two major first-line drugs for managing tuberculosis (TB), caused by the microbe Although co-use of these two drugs is common in clinical practice, the mechanism for the potential synergistic interplay between them remains unclear. Here, we present first evidence that INH and EMB act synergistically through a transcriptional repressor of the gene, the target gene of INH encoding an enoyl-acyl carrier protein reductase of the fatty acid synthase type II system required for bacterial cell wall integrity. We report that EMB binds a hypothetical transcription factor encoded by the gene, designated here as EtbR. Using DNA footprinting, we found that EtbR specifically recognizes a motif sequence in the upstream region of the gene. Using isothermal titration calorimetry and surface plasmon resonance assays, we observed that EMB binds EtbR in a 1:1 ratio and thereby stimulates its DNA-binding activity. When a nonlethal dose of EMB was delivered in combination with INH, EMB increased the INH susceptibility of cultured cells. In summary, EMB induces EtbR-mediated repression of and thereby enhances the mycobactericidal effect of INH. Our findings uncover a molecular mechanism for the synergistic activity of two important anti-TB drugs.

摘要

异烟肼(INH)和乙胺丁醇(EMB)是治疗结核病(TB)的两种主要一线药物,由微生物引起。虽然这两种药物在临床实践中经常同时使用,但它们之间潜在协同作用的机制尚不清楚。在这里,我们首次提供证据表明,INH 和 EMB 通过 INH 编码的基因的转录抑制剂发挥协同作用,该基因编码脂肪酸合成酶 II 系统的烯酰基酰基载体蛋白还原酶,这是细菌细胞壁完整性所必需的。我们报告说,EMB 结合了由基因编码的假定转录因子,这里称为 EtbR。通过 DNA 足迹实验,我们发现 EtbR 特异性识别基因上游区域的一个模体序列。通过等温滴定量热法和表面等离子体共振测定,我们观察到 EMB 以 1:1 的比例结合 EtbR,从而刺激其 DNA 结合活性。当以非致死剂量的 EMB 与 INH 联合给药时,EMB 增加了培养的细胞对 INH 的敏感性。总之,EMB 诱导 EtbR 介导的基因抑制,从而增强了 INH 的杀菌作用。我们的发现揭示了两种重要抗结核药物协同作用的分子机制。

相似文献

1
Molecular mechanism of the synergistic activity of ethambutol and isoniazid against .乙胺丁醇和异烟肼协同作用对抗 的分子机制。
J Biol Chem. 2018 Oct 26;293(43):16741-16750. doi: 10.1074/jbc.RA118.002693. Epub 2018 Sep 5.
2
The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.结核分枝杆菌iniA基因对于一种外排泵的活性至关重要,该外排泵赋予对异烟肼和乙胺丁醇的耐药性。
Mol Microbiol. 2005 Mar;55(6):1829-40. doi: 10.1111/j.1365-2958.2005.04510.x.
3
Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.一种无机配合物对结核分枝杆菌2-反式烯酰-ACP(辅酶A)还原酶的缓慢抑制作用
Curr Pharm Des. 2006;12(19):2409-24. doi: 10.2174/138161206777698927.
4
Progress on mechanism of ethambutol resistance in Mycobacterium Tuberculosis.结核分枝杆菌对乙胺丁醇耐药机制的研究进展
Yi Chuan. 2016 Oct 20;38(10):910-917. doi: 10.16288/j.yczz.16-111.
5
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.对异烟肼和乙胺丁醇均耐药的结核分枝杆菌分离株的表型和分子特征
Antimicrob Agents Chemother. 2005 Jun;49(6):2218-25. doi: 10.1128/AAC.49.6.2218-2225.2005.
6
Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.关于烟酰胺腺嘌呤二核苷酸(NADH)与结核分枝杆菌野生型及异烟肼抗性烯酰-酰基载体蛋白(CoA)还原酶结合的晶体学和稳态前动力学研究。
J Mol Biol. 2006 Jun 9;359(3):646-66. doi: 10.1016/j.jmb.2006.03.055. Epub 2006 Apr 21.
7
Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv.异烟肼、乙胺丁醇和N-香叶基-N'-(2-金刚烷基)乙烷-1,2-二胺(SQ109)对结核分枝杆菌H37Rv的药物蛋白质组学效应
J Pharmacol Exp Ther. 2005 Nov;315(2):905-11. doi: 10.1124/jpet.105.087817. Epub 2005 Aug 5.
8
Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.摩洛哥结核分枝杆菌分离株中异烟肼、链霉素和乙胺丁醇耐药性分析。
J Infect Dev Ctries. 2009 May 1;3(4):278-84. doi: 10.3855/jidc.125.
9
[Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].[对暴露于一线抗结核药物与维拉帕米联合治疗的耐药结核分枝杆菌复合群临床分离株中流出泵基因的研究]
Mikrobiyol Bul. 2023 Apr;57(2):207-219. doi: 10.5578/mb.20239916.
10
In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.齐墩果酸与异烟肼、利福平或乙胺丁醇联合抗结核分枝杆菌的体外协同作用。
J Med Microbiol. 2010 May;59(Pt 5):567-572. doi: 10.1099/jmm.0.014837-0. Epub 2010 Jan 14.

引用本文的文献

1
Isoniazid-rhodanine molecular hybrids: design, synthesis, antimycobacterial activity and computational validation.异烟肼-若丹宁分子杂化物:设计、合成、抗分枝杆菌活性及计算验证
RSC Adv. 2025 Sep 1;15(38):31272-31288. doi: 10.1039/d5ra03641k. eCollection 2025 Aug 29.
2
Incorporation of macrophage immune stresses into an assay for drug tolerance in intracellular .将巨噬细胞免疫应激纳入细胞内药物耐受性检测方法中。
bioRxiv. 2025 May 9:2025.05.09.653069. doi: 10.1101/2025.05.09.653069.
3
Nutritional Deficiencies and Management in Tuberculosis: Pharmacotherapeutic and Clinical Implications.结核病中的营养缺乏与管理:药物治疗及临床意义
Nutrients. 2025 May 30;17(11):1878. doi: 10.3390/nu17111878.
4
A conserved phage phosphoesterase enables evasion of bacterial antiviral immunity.一种保守的噬菌体磷酸二酯酶能够逃避细菌的抗病毒免疫。
EMBO Rep. 2025 May 29. doi: 10.1038/s44319-025-00488-4.
5
The fall of the mycobacterial cell wall: interrogating peptidoglycan synthesis for novel anti-TB agents.分枝杆菌细胞壁的瓦解:针对新型抗结核药物对肽聚糖合成的探索。
PeerJ. 2024 Nov 14;12:e18404. doi: 10.7717/peerj.18404. eCollection 2024.
6
Mutations in 406 Are Associated with Low-Level Ethambutol Resistance in Canadian Isolates.406位点的突变与加拿大分离株中的低水平乙胺丁醇耐药性相关。
Antibiotics (Basel). 2024 Jul 4;13(7):624. doi: 10.3390/antibiotics13070624.
7
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.高剂量异烟肼缺乏对 katG 突变介导的耐异烟肼结核病的早期杀菌活性:一项随机、Ⅱ期临床试验。
Am J Respir Crit Care Med. 2024 Aug 1;210(3):343-351. doi: 10.1164/rccm.202311-2004OC.
8
Multi-Drug-Resistant Tuberculosis Peritonitis: A Case Report.耐多药结核性腹膜炎:一例报告
Cureus. 2024 Feb 10;16(2):e53975. doi: 10.7759/cureus.53975. eCollection 2024 Feb.
9
An Update to Novel Therapeutic Options for Combating Tuberculosis: Challenges and Future Prospectives.新型抗结核治疗选择的最新进展:挑战与未来展望。
Curr Pharm Biotechnol. 2024;25(14):1778-1790. doi: 10.2174/0113892010246389231012041120.
10
Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity.与乙胺丁醇治疗结果及毒性易感性相关的基因多态性
Front Genet. 2023 Apr 20;14:1118102. doi: 10.3389/fgene.2023.1118102. eCollection 2023.

本文引用的文献

1
Novel Pharmacological Activity of Artesunate and Artemisinin: Their Potential as Anti-Tubercular Agents.青蒿琥酯和青蒿素的新型药理活性:它们作为抗结核药物的潜力
J Clin Med. 2017 Mar 10;6(3):30. doi: 10.3390/jcm6030030.
2
Novel TetR family transcriptional factor regulates expression of multiple transport-related genes and affects rifampicin resistance in Mycobacterium smegmatis.新型 TetR 家族转录因子调控多个转运相关基因的表达并影响耻垢分枝杆菌对利福平的耐药性。
Sci Rep. 2016 Jun 7;6:27489. doi: 10.1038/srep27489.
3
A GntR family transcription factor positively regulates mycobacterial isoniazid resistance by controlling the expression of a putative permease.一种GntR家族转录因子通过控制一种假定通透酶的表达来正向调节分枝杆菌对异烟肼的耐药性。
BMC Microbiol. 2015 Oct 16;15:214. doi: 10.1186/s12866-015-0556-8.
4
Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.结核分枝杆菌耐药机制:2015年更新
Int J Tuberc Lung Dis. 2015 Nov;19(11):1276-89. doi: 10.5588/ijtld.15.0389.
5
Cyclic diguanylate monophosphate directly binds to human siderocalin and inhibits its antibacterial activity.环二鸟苷单磷酸直接与人铁调素结合并抑制其抗菌活性。
Nat Commun. 2015 Sep 22;6:8330. doi: 10.1038/ncomms9330.
6
InbR, a TetR family regulator, binds with isoniazid and influences multidrug resistance in Mycobacterium bovis BCG.InbR是一种四环素阻遏蛋白家族调控因子,它与异烟肼结合并影响卡介苗中的多药耐药性。
Sci Rep. 2015 Sep 10;5:13969. doi: 10.1038/srep13969.
7
Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France.法国结核分枝杆菌临床分离株中与乙胺丁醇耐药性相关的embCAB基因座和embR基因的分子分析
Antimicrob Agents Chemother. 2015 Aug;59(8):4800-8. doi: 10.1128/AAC.00150-15. Epub 2015 Jun 1.
8
The DNA-binding network of Mycobacterium tuberculosis.结核分枝杆菌的DNA结合网络。
Nat Commun. 2015 Jan 12;6:5829. doi: 10.1038/ncomms6829.
9
Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol.embC-embA基因间区域的突变导致结核分枝杆菌对乙胺丁醇耐药。
Antimicrob Agents Chemother. 2014 Nov;58(11):6837-43. doi: 10.1128/AAC.03285-14. Epub 2014 Sep 2.
10
A TetR family transcriptional factor directly regulates the expression of a 3-methyladenine DNA glycosylase and physically interacts with the enzyme to stimulate its base excision activity in Mycobacterium bovis BCG.TetR 家族转录因子直接调控 3-甲基腺嘌呤 DNA 糖基化酶的表达,并与该酶相互作用以刺激其在牛分枝杆菌 BCG 中的碱基切除活性。
J Biol Chem. 2014 Mar 28;289(13):9065-75. doi: 10.1074/jbc.M113.528919. Epub 2014 Feb 7.